Log in to save to my catalogue

2139: PBX1 mRNA expression is a prognostic biomarker of and clinical indicator by RT-qPCR and RNASco...

2139: PBX1 mRNA expression is a prognostic biomarker of and clinical indicator by RT-qPCR and RNASco...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6798987

2139: PBX1 mRNA expression is a prognostic biomarker of and clinical indicator by RT-qPCR and RNAScope

About this item

Full title

2139: PBX1 mRNA expression is a prognostic biomarker of and clinical indicator by RT-qPCR and RNAScope

Publisher

Cambridge, UK: Cambridge University Press

Journal title

Journal of clinical and translational science, 2018-05, Vol.1 (Suppl 1), p.57-57

Language

English

Formats

Publication information

Publisher

Cambridge, UK: Cambridge University Press

Subjects

More information

Scope and Contents

Contents

OBJECTIVES/SPECIFIC AIMS: (1) Correlate PBX1 mRNA expression as measured by RNAScope in situ hybridization, at an RNA number/cell measurement, Versus by RT-qPCR by the ddCt method. (2) Validate PBX1 mRNA expression in a second independent cohort of neuroblastoma tumor samples, and correlate with patient outcomes. We expect that PBX1 expression will...

Alternative Titles

Full title

2139: PBX1 mRNA expression is a prognostic biomarker of and clinical indicator by RT-qPCR and RNAScope

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6798987

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6798987

Other Identifiers

E-ISSN

2059-8661

DOI

10.1017/cts.2017.205

How to access this item